BMEA vs BNTC

Biomea Fusion, Inc. vs Benitec Biopharma Inc. — Valuation Comparison 2026

BMEA

Pharmaceutical Preparations
Biomea Fusion, Inc.
Quality
4.0
out of 10
Value Trap
24
SAFE
Price
$1.38
Last close
Models
9/13
Active
VS

BNTC

Pharmaceutical Preparations
Benitec Biopharma Inc.
Quality
4.4
out of 10
Value Trap
45
WARN
Price
$11.56
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType BMEA Fair ValueBMEA Upside BNTC Fair ValueBNTC Upside
Bayesian DCF Intrinsic $0.50 -63.7% $5.90 -49.0%
Earnings Power Value Intrinsic $1.22 -10.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.65 +19.8% $5.93 -48.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BMEA vs BNTC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BMEA vs BNTC — Which Stock Is More Undervalued?

BNTC scores higher with a 4.4/10 quality rating vs BMEA's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biomea Fusion, Inc. (BMEA) and Benitec Biopharma Inc. (BNTC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BMEA currently trades at $1.38 with a QOC of 4.0/10, while BNTC trades at $11.56 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).